BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 14130832)

  • 1. HORMONAL DISTURBANCES IN THE ELDERLY.
    SPENCE AW
    Practitioner; 1964 Mar; 192():363-9. PubMed ID: 14130832
    [No Abstract]   [Full Text] [Related]  

  • 2. HORMONES AND THE MENOPAUSE.
    BENDER S
    Practitioner; 1964 Mar; 192():359-62. PubMed ID: 14130831
    [No Abstract]   [Full Text] [Related]  

  • 3. DIAGNOSIS AND TREATMENT OF OSTEOPOROSIS.
    CHU LS; ABRAMSON DI
    Geriatrics; 1963 Sep; 18():679-92. PubMed ID: 14057009
    [No Abstract]   [Full Text] [Related]  

  • 4. EFFECTS OF ANDROGENS, ESTROGENS AND HIGH CALCIUM INTAKES ON BONE FORMATION AND RESORPTION IN OSTEOPOROSIS.
    LAFFERTY FW; SPENCER GE; PEARSON OH
    Am J Med; 1964 Apr; 36():514-28. PubMed ID: 14142405
    [No Abstract]   [Full Text] [Related]  

  • 5. [VARIOUS PROBLEMS IN UROLOGY, ESPECIALLY ON THE RENOGRAM IN MALE STERILITY].
    SHIDA K
    Kita Kanto Igaku; 1963; 13():131-42. PubMed ID: 14102228
    [No Abstract]   [Full Text] [Related]  

  • 6. TREATMENT OF SENILE OSTEOPOROSIS WITH AN ORALLY ADMINISTERED ANDROGEN-ESTROGEN PREPARATION.
    KNIGHT MP
    J Am Geriatr Soc; 1964 Apr; 12():395-8. PubMed ID: 14140984
    [No Abstract]   [Full Text] [Related]  

  • 7. [THYROIDEOPATHIES AND GYNECOMASTY].
    MARTINEZ DJ; MARTINEZ JD; DEMARTINEZ NR; FOSSATI RL; MELHEM E
    Sem Med; 1963 Dec; 123():2024-5. PubMed ID: 14161872
    [No Abstract]   [Full Text] [Related]  

  • 8. TREATMENT OF OSTEOPOROSIS.
    MCINTOSH HW
    Can Med Assoc J; 1965 Jan; 92(4):185-6. PubMed ID: 14232195
    [No Abstract]   [Full Text] [Related]  

  • 9. [MYXEDEMA AFTER TREATMENT OF HYPERTHYROIDISM WITH RADIOIODINE].
    ANNO Y; HARA M
    Rinsho Hoshasen; 1963 Dec; 8():895-901. PubMed ID: 14101288
    [No Abstract]   [Full Text] [Related]  

  • 10. HORMONAL THERAPY OF METASTATIC FEMALE BREAST CARCINOMA. V. PHENOL,4,4'-(DL-1,2-DIETHYL-ETHYLENE)DI- AND ANDROST-4-EN-3-ONE, 9-CHLORO-11-BETA, 17-BETA-DIHYDROXY-17-METHYL-.
    GOLDENBERG IS; HAYES MA; MORIN JE
    Cancer; 1965 Apr; 18():447-9. PubMed ID: 14278041
    [No Abstract]   [Full Text] [Related]  

  • 11. [HYPERTHYROIDISM. ON RESULTS AND AN EVALUATION OF THE EFFECTS OF CONSERVATIVE TREATMENT].
    MIYAKE T; SHIMATSUKA K; KUSAKABE T; INADA M
    Sogo Rinsho; 1963 Nov; 12():2135-48. PubMed ID: 14096536
    [No Abstract]   [Full Text] [Related]  

  • 12. [TREATMENT OF A MENOPAUSAL SYNDROME WITH A COMBINED ESTROGEN-ANDROGEN (AMBOSEX) PREPARATION].
    SAS M; FARKAS M; SZEGVARI M
    Magy Noorv Lapja; 1963 Nov; 26():337-43. PubMed ID: 14108052
    [No Abstract]   [Full Text] [Related]  

  • 13. Secondary hormonal therapy of disseminated breast cancer. Comparison of hypophysectomy, replacement therapy, estrogens, and androgens.
    WITT JA; GARDNER B; GORDAN GS; GRAHAM WP; THOMAS AN
    Arch Intern Med; 1963 May; 111():557-63. PubMed ID: 14001394
    [No Abstract]   [Full Text] [Related]  

  • 14. IODOTYROSINE-LIKE SUBSTANCES IN HUMAN SERUM.
    DIMITRIADOU A; FRASER R; TURNER PC
    Nature; 1964 Feb; 201():575-8. PubMed ID: 14160641
    [No Abstract]   [Full Text] [Related]  

  • 15. SOME PRESENT DAY CONCEPTS OF THE THERAPY OF DISEASES OF THE THYROID GLAND.
    HAMOLSKY MW
    R I Med J; 1964 Jul; 47():336-9. PubMed ID: 14179935
    [No Abstract]   [Full Text] [Related]  

  • 16. THE HORMONES AND PUBERTY.
    DEMOWBRAY RR
    Practitioner; 1964 Mar; 192():333-42. PubMed ID: 14130828
    [No Abstract]   [Full Text] [Related]  

  • 17. Further studies on the rate of disappearance of labelled thyroxine from the intravascular compartment of man, with reference to the role of thyroxine binding proteins.
    Webster BR; Britton A; Volpé R; Ezrin C
    Acta Endocrinol (Copenh); 1967 Jul; 55(3):497-521. PubMed ID: 4962130
    [No Abstract]   [Full Text] [Related]  

  • 18. Antifracture efficacy of long-term estrogens for osteoporosis.
    Gordan GS; Picchi J; Roof BS
    Trans Assoc Am Physicians; 1973; 86():326-32. PubMed ID: 4363387
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fermandren: ethinyl-estradiol g 0.005, methyltestosterone g 0.0025, for a sublingual tablet].
    Farmaco Prat; 1953 Apr; 8(4):211-2. PubMed ID: 13095472
    [No Abstract]   [Full Text] [Related]  

  • 20. DIFFERENCES IN THE INTERACTION OF TRIIODOTHYRONINE-131-I WITH SERUM PROTEINS IN VITRO.
    MITCHELL ML; BRADFORD AH; COLLINS S
    J Clin Endocrinol Metab; 1964 Sep; 24():867-74. PubMed ID: 14216476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.